Safety-Related Labeling Changes

Myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML)

Trade Name

Nivestim

Updated Section

"4.4 Special warnings and precautions for use, 4.8 Undesirable effect"

Month

Jul, 2025